SELAS DE PHARMACIENS D'OFFICINE GRANDE PHARMACIE HYEROISE : revenue, balance sheet and financial ratios

SELAS DE PHARMACIENS D'OFFICINE GRANDE PHARMACIE HYEROISE is a French company founded 20 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in HYERES (83400), this company of category PME shows in 2022 a revenue of 5.4 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Historique financier - SELAS DE PHARMACIENS D'OFFICINE GRANDE PHARMACIE HYEROISE (SIREN 489706135)
Kennzahl 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Umsatz N/C N/C N/C 5 415 085 € 4 750 937 € 5 025 630 € N/C N/C N/C 3 985 051 €
Nettoergebnis 253 183 € 168 867 € 108 701 € 355 384 € 135 716 € 155 106 € 184 211 € 140 341 € 129 382 € 172 557 €
EBITDA N/C N/C N/C 552 316 € 268 472 € 263 740 € N/C N/C N/C 318 920 €
Nettomarge N/C N/C N/C 6.6% 2.9% 3.1% N/C N/C N/C 4.3%

Umsatz und Gewinn- und Verlustrechnung

In 2025, SELAS DE PHARMACIENS D'OFFICINE GRANDE PHARMACIE HYEROISE generates positive net income of 253 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 173 k€ -> 253 k€.

Nettoergebnis (2025) ?
Nettoergebnis
Definition
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Formel
Ordentliches Ergebnis + Außerordentliches Ergebnis - Ertragsteuern

253 183 €

Chargement du compte de résultat...

Évolution graphique

Anzeigen :

Aktiva

Chargement des données...

Passiva

Chargement des données...

Solvenz- und Verschuldungskennzahlen

The debt ratio (= Financial debt / Equity x 100) stands at 160%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 10%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Verschuldungsgrad (2025) ?
Verschuldungsgrad
Definition
Misst das Verhältnis von Schulden zu Eigenkapital.
Formel
(Finanzschulden / Eigenkapital) x 100
Interpretation
< 50% : Faible
50-100% : Moderat
> 100% : Hoch

159.597%

Finanzielle Autonomie (2025) ?
Finanzielle Autonomie
Definition
Anteil des Eigenkapitals an der Gesamtfinanzierung.
Formel
(Eigenkapital / Bilanzsumme) x 100
Interpretation
> 30% : Gute Autonomie
20-30% : Durchschnitt
< 20% : Faible

10.297%

Anlagenaltersquote (2025) ?
Anlagenaltersquote
Definition
Misst den Abnutzungsgrad des Sachanlagevermögens.
Formel
Kumulierte Abschreibungen / Bruttoanlagevermögen x 100
Interpretation
< 50% : Neue Anlagen
50-70% : Normale Abnutzung
> 70% : Alternde Anlagen

36.0%

Entwicklung der Solvenzkennzahlen
SELAS DE PHARMACIENS D'OFFICINE GRANDE PHARMACIE HYEROISE

Positionnement sectoriel

Debt ratio
159.6 2025
2023
2024
2025
Q1: 13.7
Méd: 49.79
Q3: 129.09
Average +23 pts über 3 Jahre

In 2025, the debt ratio of SELAS DE PHARMACIENS D'OF... (159.60) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
10.3% 2025
2023
2024
2025
Q1: 33.42%
Méd: 53.72%
Q3: 72.08%
Watch -11 pts über 3 Jahre

In 2025, the financial autonomy of SELAS DE PHARMACIENS D'OF... (10.3%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Liquiditätskennzahlen

The liquidity ratio (= Current assets / Current liabilities) stands at 72.78. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquiditätsquote (2025) ?
Liquiditätsquote
Definition
Fähigkeit, kurzfristige Schulden mit dem Umlaufvermögen zu decken.
Formel
Umlaufvermögen / Kurzfristige Verbindlichkeiten
Interpretation
> 1.5 : Sehr gut
1-1.5 : Angemessen
< 1 : Risque de liquidité

72.784

Entwicklung der Liquiditätskennzahlen
SELAS DE PHARMACIENS D'OFFICINE GRANDE PHARMACIE HYEROISE

Positionnement sectoriel

Liquidity ratio
72.78 2025
2023
2024
2025
Q1: 131.03
Méd: 182.25
Q3: 258.64
Watch -10 pts über 3 Jahre

In 2025, the liquidity ratio of SELAS DE PHARMACIENS D'OF... (72.78) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Umlaufvermögensbedarf und Zahlungsfristen

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operatives Working Capital (2025) ?
Operatives Working Capital
Definition
Besoin de financement généré par le cycle d'exploitation (stocks + créances - dettes fournisseurs).
Formel
Stocks + Créances clients - Dettes fournisseurs
Interpretation
Negativ = freigesetzte Liquidität
Positiv = Finanzierungsbedarf

0 €

Kundenforderungen (2025) ?
Kundenforderungen (Tage)
Definition
Durchschnittliche Zahlungsfrist für Kunden.
Formel
(Kundenforderungen / Umsatz inkl. MwSt.) x 360
Interpretation
< 45j : Gut
45-60j : Durchschnitt
> 60j : Lang

0 j

Lieferantenverbindlichkeiten (2025) ?
Lieferantenverbindlichkeiten (Tage)
Definition
Durchschnittliche Zahlungsfrist von Lieferanten.
Formel
(Lieferantenverbindlichkeiten / Einkäufe inkl. MwSt.) x 360
Interpretation
Je länger die Frist, desto besser für die Liquidität

0 j

Lagerumschlag (2025) ?
Lagerumschlag (Tage)
Definition
Durchschnittliche Lagerdauer für Waren oder Materialien.
Formel
(Vorräte / Einkaufskosten) x 360
Interpretation
Je niedriger das Verhältnis, desto schneller der Umschlag

0 j

Entwicklung des Working Capital und der Zahlungsfristen
SELAS DE PHARMACIENS D'OFFICINE GRANDE PHARMACIE HYEROISE

Positionnement de SELAS DE PHARMACIENS D'OFFICINE GRANDE PHARMACIE HYEROISE dans son secteur

Vergleich mit der Branche Commerce de détail de produits pharmaceutiques en magasin spécialisé

Bewertungsschätzung

Based on 277 transactions of similar company sales in 2025, the value of SELAS DE PHARMACIENS D'OFFICINE GRANDE PHARMACIE HYEROISE is estimated at 4 021 842 € (range 2 729 241€ - 6 310 824€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
2729k€ 4021k€ 6310k€
4 021 842 € Range: 2 729 241€ - 6 310 824€
NAF 5 année 2025

Valuation method used

Net Income Multiple
253 183 € × 15.9x = 4 021 842 €
Range: 2 729 241€ - 6 310 824€

Only this financial indicator is available for this company.

Bewertungsentwicklung

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELAS DE PHARMACIENS D'OFFICINE GRANDE PHARMACIE HYEROISE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELAS DE PHARMACIENS D'OFFICINE GRANDE PHARMACIE HYEROISE

What is the revenue of SELAS DE PHARMACIENS D'OFFICINE GRANDE PHARMACIE HYEROISE ?

The revenue of SELAS DE PHARMACIENS D'OFFICINE GRANDE PHARMACIE HYEROISE in 2022 is 5.4 M€.

Is SELAS DE PHARMACIENS D'OFFICINE GRANDE PHARMACIE HYEROISE profitable?

Yes, SELAS DE PHARMACIENS D'OFFICINE GRANDE PHARMACIE HYEROISE generated a net profit of 253 k€ in 2025.

Where is the headquarters of SELAS DE PHARMACIENS D'OFFICINE GRANDE PHARMACIE HYEROISE ?

The headquarters of SELAS DE PHARMACIENS D'OFFICINE GRANDE PHARMACIE HYEROISE is located in HYERES (83400), in the department Var.

Where to find the tax return of SELAS DE PHARMACIENS D'OFFICINE GRANDE PHARMACIE HYEROISE ?

The tax return of SELAS DE PHARMACIENS D'OFFICINE GRANDE PHARMACIE HYEROISE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELAS DE PHARMACIENS D'OFFICINE GRANDE PHARMACIE HYEROISE operate?

SELAS DE PHARMACIENS D'OFFICINE GRANDE PHARMACIE HYEROISE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.